SiVEC Biotechnologies’ delivery platform enables tissue specific delivery of nucleic acid therapeutics and vaccines
BIOLOGICAL PLATFORM FOR NUCLEIC ACID DRUG AND VACCINE DELIVERY
SiVEC’s delivery platform uses non-pathogenic bacteria for targeted intracellular delivery of nucleic acid drugs and vaccines to mucosal epithelial cells. SiVEC is seeking to partner with companies who can benefit from using this delivery platform to make their drug or vaccine more efficacious.
SiVEC-IAV™ - A SiRNA THERAPEUTIC FOR PREVENTION & TREATMENT OF FLU
Using SiVEC’s proprietary delivery platform, we have developed SiVEC-IAV, a biological antiviral for prophylaxis and treatment of influenza (flu). SiVEC-IAV is delivered by inhalation or intranasal spray for fast local deposition in respiratory tissues, without systemic adsorption.
SiVEC-AIV™ - A POTENT ANTIVIRAL FOR AVIAN FLU
SiVEC Biotechnologies is developing SiVEC-AIV™ as an innovative solution to treat and prevent the world’s most devastating poultry disease, avian flu.